Karen Ling
CIK 1597450 · EVP and Chief HR Officer · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.20M
Companies
9
Total Filings
54
Lifetime Open-Market Net
$96.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRTC | Director | 11,141 | $113.65 | $1.27M | $0 | 7 | 2026-05-29 |
| BLCO | Director | 61,518 | $15.08 | $927.7K | $71.0K | 5 | 2026-05-28 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 49,399 | $0.34 | $16.8K | $0 | 4 | 2023-06-29 |
| TXMD | Director | 4,591 | $2.20 | $10.1K | $25.1K | 6 | 2022-10-03 |
| AMERICAN INTERNATIONAL GROUP, INC. (AIGpA) Delisted | EVP and Chief HR Officer | 10,809 | $24.99 | $270.1K | $0 | 12 | 2021-04-01 |
| Allergan plc (AGN) Delisted | EVP & Chief H.R. Officer | 25,132 | — | — | $0 | 4 | 2019-04-05 |
| Allergan plc (AGNpA) Delisted | Chief Human Resources Officer | 27,873 | — | — | $0 | 8 | 2018-01-02 |
| Allergan plc (ACTpA) Delisted | Chief Human Resources Officer | 22,543 | — | — | $0 | 3 | 2015-05-19 |
| Forest Laboratories, LLC (FRX) Delisted | SVP - Chief HR Officer | 0 | $12.00 | $0 | $0 | 2 | 2014-07-02 |
Recent Filings · Page 2 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-29 | Keenova Therapeutics plc (MNK) Delisted | Mixed | −29,431 | -$4.0K | EDGAR |
| 2023-05-25 | IRTC | Grant (A) | +1,164 | $0 | EDGAR |
| 2023-01-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +26,277 | $0 | EDGAR |
| 2022-10-03 | TXMD | Grant (A) | — | $0 | EDGAR |
| 2022-09-15 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-14 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-22 | TXMD | Exer (M) | +1,984 | $0 | EDGAR |
| 2022-05-31 | IRTC | Grant (A) | +653 | $0 | EDGAR |
| 2021-11-04 | IRTC | Grant (A) | +4,320 | $0 | EDGAR |
| 2021-08-19 | TXMD | Buy (P) | +33,445 | $25.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.